Context Therapeutics Inc
F:6K9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Context Therapeutics Inc
F:6K9
|
US |
|
H
|
Huntington Ingalls Industries Inc
SWB:HI4
|
US |
|
N
|
Nordstrom Inc
DUS:NRD
|
US |
|
N
|
Nissan Chemical Corp
DUS:NSC
|
JP |
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
George Weston Ltd
TSX:WN
|
CA |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
Y
|
Ypsomed Holding AG
XBER:OWX
|
CH |
|
I
|
IAMGOLD Corp
SWB:IAL
|
CA |
|
K
|
Kinross Gold Corp
DUS:KIN2
|
CA |
|
F
|
Franklin Resources Inc
BMV:BEN
|
US |
|
J&T Global Express Ltd
F:J92
|
CN |
|
Stabilis Solutions Inc
NASDAQ:SLNG
|
US |
|
T
|
Texas Instruments Inc
F:TII
|
US |
|
Avery Dennison Corp
NYSE:AVY
|
US |
|
D
|
Dycom Industries Inc
SWB:DYI
|
US |
|
COSCO SHIPPING Development Co Ltd
OTC:CITAF
|
CN |
|
Unicharm Corp
TSE:8113
|
JP |
|
K
|
Kroger Co
XMUN:KOG
|
US |
|
Analog Devices Inc
NASDAQ:ADI
|
US |
|
O
|
Omega Healthcare Investors Inc
F:WX4
|
US |
|
China Coal Energy Co Ltd
OTC:CCOZY
|
CN |
|
Takasago Thermal Engineering Co Ltd
F:Q74
|
JP |
|
A
|
Air Products and Chemicals Inc
DUS:AP3
|
US |
Wall St Price Targets
6K9 Price Targets Summary
Context Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6K9's stock price target?
Price Target
3.707
EUR
According to Wall Street analysts, the average 1-year price target for
6K9 is 3.707 EUR with a low forecast of 2.447 EUR and a high forecast of 5.088 EUR.